Supply Chain

The FDA's Center for Devices and Radiological Health plans to expand its digital health pre-certification pilot program by the end of 2018, the center's associate director for digital health Bakul Patel said March 22, according to Regulatory Focus.

HHS Secretary Alex Azar selected CVS Caremark Vice President Daniel Best to lead the agency's push to curb drug prices, a source familiar with the hire told Politico.

The American Red Cross was forced to cancel more than 350 blood drives in March as a string of winter storms pummeled the U.S. — greatly depleting blood supply across the nation. 

Monteris Medical recalled its NeuroBlate System and coinciding Laser Delivery Probes due to numerous instances of device malfunctions, according to a March 22 recall alert from the FDA.

GlaxoSmithKline reportedly pulled its bid to purchase Pfizer's consumer healthcare business March 23, according to Reuters.

President Donald Trump's administration implemented a payment policy change that could increase the price of biosimilars, according to The Wall Street Journal.

Here are the four latest drugs or medical devices approved by the FDA since March 9.

Americans identified pharmaceutical companies as one of the most influential parties in Washington, D.C., in a poll conducted by Kaiser Family Foundation.

In the wake of the IV fluid bag shortage sparked by Hurricane Maria, which slammed Puerto Rico in September, Boston-based Brigham and Women's Hospital is using oral hydration protocol to curb IV fluid bag use, according to an article published…

The U.S. Patent and Trademark Office granted Amazon a new patent last week for a delivery drone that can react to human gestures, including screaming, flailing and a thumbs-up, reports the Los Angeles Times.